NASDAQ: BVS
Bioventus Inc Stock Ownership - Who owns Bioventus?

Insider buying vs selling

Have Bioventus Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Katrina J. ChurchSVP Chief Compliance Officer2026-04-101,868$9.06
$16.92kSell
Mark Leonard SingletonSVP CFO2026-04-105,648$9.06
$51.17kSell
Anthony DadamioSVP General Counsel2026-04-104,312$9.06
$39.07kSell
Mark Leonard SingletonSVP CFO2026-03-208,091$8.64
$69.91kSell
Anthony DadamioSVP General Counsel2026-03-133,861$8.62
$33.28kSell
Anthony DadamioSVP General Counsel2026-03-133,802$8.62
$32.77kSell
Katrina J. ChurchSVP Chief Compliance Officer2026-03-131,501$8.62
$12.94kSell
Katrina J. ChurchSVP Chief Compliance Officer2026-03-131,521$8.62
$13.11kSell
Robert E. ClaypoolePresident and CEO2026-03-1314,553$8.62
$125.45kSell
Mark Leonard SingletonSVP CFO2026-03-135,865$8.62
$50.56kSell

1 of 2

BVS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BVS insiders and whales buy or sell their stock.

BVS Shareholders

What type of owners hold Bioventus Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Smith Nephew PLC19.79%16,534,814$173.62MInsider
Juniper Investment Company LLC15.76%13,168,697$138.27MInsider
Martin P. Sutter15.69%13,106,565$137.62MInsider
Ew Healthcare Partners Acquisition Fund LP15.59%13,021,324$136.72MInsider
Essex Woodlands Management Inc15.59%13,021,324$136.72MInstitution
John A. Bartholdson8.40%7,018,977$73.70MInsider
Juniper Investment Company LLC8.31%6,939,357$72.86MInstitution
Nantahala Capital Management LLC7.24%6,047,403$63.50MInstitution
Spindletop Healthcare Capital LP4.68%3,906,395$41.02MInsider
Ampcf Holdings LLC3.90%3,255,332$34.18MInsider

1 of 3

BVS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BVS38.43%61.57%Net SellingNet Selling
INMD53.86%11.96%
SGP0.00%100.00%Net Buying
CBLL71.90%28.10%Net SellingNet Selling
LMRI29.42%0.43%

Bioventus Stock Ownership FAQ

Who owns Bioventus?

Bioventus (NASDAQ: BVS) is owned by 60.10% institutional shareholders, 96.30% Bioventus insiders, and 0.00% retail investors. Smith Nephew PLC is the largest individual Bioventus shareholder, owning 16.53M shares representing 19.79% of the company. Smith Nephew PLC's Bioventus shares are currently valued at $173.62M.

If you're new to stock investing, here's how to buy Bioventus stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.